Literature DB >> 29607768

The Dutch Hip and Groin Outcome Score: Cross-cultural Adaptation and Validation According to the COSMIN Checklist.

Igor Tak, Marsha Tijssen, Thijs Schamp, Inger Sierevelt, Kristian Thorborg, Gino Kerkhoffs, Janine Stubbe, Anne-Marie van Beijsterveldt, Daniel Haverkamp.   

Abstract

Study Design Clinical measurement. Background The Copenhagen Hip and Groin Outcome Score (HAGOS) was developed as a patient-reported outcome measure for young, active individuals with hip and groin pain. Objectives To cross-culturally adapt and validate a Dutch version of the HAGOS. Methods Adaptation and validation were performed according to existing guidelines and the COnsensus-based Standards for the selection of health Measurement INstruments checklist. Physically active (Tegner activity score of greater than 2) adults between 18 and 50 years of age with hip and groin pain (numeric pain score of 1 or greater) were included in the study. Reliability (test-retest, internal consistency) was assessed in clinically stable patients. Construct validity was determined by calculating Spearman correlations between the scores on the HAGOS and scores on the Hip disability and Osteoarthritis Outcome Score and European Quality of Life-5 Dimensions subscales. Fifteen hypotheses were defined a priori. Interpretability was considered good when floor and ceiling effects were present in less than 15% of individuals. Results A Dutch version of the HAGOS was created. Its reliability was tested in 129 individuals and its validity in 194 participants. Test-retest reliability was good (intraclass correlation coefficient = 0.83-0.87). Internal consistency was good (Cronbach α = .81-.92). Construct validity was considered good: 13 of 15 (87%) hypotheses were confirmed. Floor effects (21%) were present for the physical activity subscale. Conclusion The Dutch HAGOS is a reliable and valid patient-reported outcome measure and performs similarly to the original version in its target population. It can be used in clinical as well as research settings. Presence of floor effects should be considered for the physical activity subscale. J Orthop Sports Phys Ther 2018;48(4):299-306. doi:10.2519/jospt.2018.7883.

Entities:  

Keywords:  HAGOS; groin; hip; outcome measure

Mesh:

Year:  2018        PMID: 29607768     DOI: 10.2519/jospt.2018.7883

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  5 in total

1.  The Brazilian hip and groin outcome score (HAGOS-Br): cross-cultural adaptation and measurement properties.

Authors:  Luciana De Michelis Mendonça; Paulo Ricardo Pinto Camelo; Giulianne Cristine Capovilla Trevisan; Flávio Fernandes Bryk; Kristian Thorborg; Rodrigo Ribeiro Oliveira
Journal:  Braz J Phys Ther       Date:  2021-11-12       Impact factor: 3.377

2.  Development of a valid Chinese version of the Cumberland Ankle Instability Tool in Chinese-speaking patients with chronic ankle instability disorders.

Authors:  Wei Wang; Dongfa Liao; Xia Kang; Wei Zheng; Wei Xu; Song Chen; Qingyun Xie
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

3.  Adaptation and psychometric evaluation of the simplified Chinese version of the identification of functional ankle instability questionnaire in Chinese-speaking patients with chronic ankle instability disorders.

Authors:  Wei Wang; Jun Sheng; Yinchao Tang; Qingyun Xie; Meng Wei; Zhiqiang Li; Wei Zheng
Journal:  BMC Musculoskelet Disord       Date:  2020-05-25       Impact factor: 2.362

4.  Characteristics of Biomechanical and Physical Function According to Symptomatic and Asymptomatic Acetabular Impingement Syndrome in Young Adults.

Authors:  Junyong Zhang; Yonghwan Kim; Moonyoung Choi; Cong Zhang
Journal:  Healthcare (Basel)       Date:  2022-08-07

5.  Hip and groin injury is the most common non-time-loss injury in female amateur football.

Authors:  Rob Langhout; Adam Weir; Wendy Litjes; Maarten Gozeling; Janine H Stubbe; Gino Kerkhoffs; Igor Tak
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-06-02       Impact factor: 4.342

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.